Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F H Messerli

Circulation

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Circulation|March 18, 1997
Nifedipine trialsF H Messerli
Circulation|October 31, 2001
Confusing Press Releases and the PREVENT StudyF H Messerli
Circulation|March 1, 1990
Antihypertensive therapy--going to the heart of the matterF H Messerli
Circulation|May 1, 1993
Does obesity influence early target organ damage in hypertensive patients?R E Schmieder, F H Messerli
Circulation|September 1, 1995
Nifedipine and mortality. Grave defects in the dossierL H Opie, F H Messerli
Circulation|December 1, 1989
Effects of antihypertensive therapy on hypertensive heart diseaseF H Messerli, U R Kaesser, C J Losem
Circulation|May 1, 1987
Cardiovascular effects of verapamil in patients with essential hypertensionR E Schmieder, F H Messerli, G E Garavaglia, et al.
Circulation|September 1, 1978
Systemic and regional hemodynamics in low, normal and high cardiac output borderline hypertensionF H Messerli, J G De Carvalho, B Christie, et al.
Circulation|October 1, 1988
Dietary salt intake. A determinant of cardiac involvement in essential hypertensionR E Schmieder, F H Messerli, G E Garavaglia, et al.
Circulation|January 1, 1986
Immediate and short-term hemodynamic effects of diltiazem in patients with hypertensionC Amodeo, I Kobrin, H O Ventura, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Circulation|March 18, 1997
Nifedipine trialsF H Messerli
Circulation|October 31, 2001
Confusing Press Releases and the PREVENT StudyF H Messerli
Circulation|March 1, 1990
Antihypertensive therapy--going to the heart of the matterF H Messerli
Circulation|May 1, 1993
Does obesity influence early target organ damage in hypertensive patients?R E Schmieder, F H Messerli
Circulation|September 1, 1995
Nifedipine and mortality. Grave defects in the dossierL H Opie, F H Messerli
Circulation|December 1, 1989
Effects of antihypertensive therapy on hypertensive heart diseaseF H Messerli, U R Kaesser, C J Losem
Circulation|May 1, 1987
Cardiovascular effects of verapamil in patients with essential hypertensionR E Schmieder, F H Messerli, G E Garavaglia, et al.
Circulation|September 1, 1978
Systemic and regional hemodynamics in low, normal and high cardiac output borderline hypertensionF H Messerli, J G De Carvalho, B Christie, et al.
Circulation|October 1, 1988
Dietary salt intake. A determinant of cardiac involvement in essential hypertensionR E Schmieder, F H Messerli, G E Garavaglia, et al.
Circulation|January 1, 1986
Immediate and short-term hemodynamic effects of diltiazem in patients with hypertensionC Amodeo, I Kobrin, H O Ventura, et al.
Pageof 2